Covered recipient · General Payments record
BURT WEBB
General Payments · PY2019–2023
$4,344.67
- Reported across 150 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $196.02 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $84.39 | 4 |
| Astellas Pharma US Inc | $66.58 | 3 |
| MILLICENT US INC | $17.00 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $14.23 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (10)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2019202020212022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $18.86 | 01/18/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999549485 | CMS |
| AbbVie Inc. | $22.01 | 02/06/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999549495 | CMS |
| AbbVie Inc. | $24.11 | 07/26/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999549505 | CMS |
| AbbVie Inc. | $19.41 | 08/17/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999549517 | CMS |
| Astellas Pharma US Inc | $17.96 | 06/06/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034144231 | CMS |
| Astellas Pharma US Inc | $22.80 | 06/28/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034237055 | CMS |
| Astellas Pharma US Inc | $25.82 | 08/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1034398741 | CMS |
| Azurity Pharmaceuticals, Inc. | $13.82 | 05/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 989005401 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $14.23 | 09/11/2023 | Food and Beverage | Undisputed | 06/30/2026 | 999996397 | CMS |
| MILLICENT US INC | $17.00 | 09/12/2023 | Food and Beverage | Undisputed | 06/30/2026 | 1027057137 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.